Digest Network Come funziona
Network
/
Società
Ae
Non verificato

Aera Therapeutics

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieSaluteSanità

5 comunicati stampa

Guarda tutti i comunicati
02/12/2025
Eventi
Fiere
Industria
Scienza
Medicina - Varie
Biotecnologia
Sanità
Salute
Farmaceutica
Aera Therapeutics to Present Preclinical Data on AERA-109, a Targeted In Vivo CAR-T Therapy for B Cell-mediated Autoimmune Diseases, at the 67th American Society of Hematology (ASH) Annual Meeting
Fonte
Aera Therapeutics
Emittente
Business Wire
1.00
0
05/11/2025
Eventi
Biotecnologia
Farmaceutica
Salute
Aera Therapeutics Announces Participation in Upcoming Investor Conferences
Fonte
Aera Therapeutics
Emittente
Business Wire
1.00
0
24/09/2025
Industria
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Aera Therapeutics Presents Preclinical Data and Announces Nomination of First Development Candidate, AERA-109, a Targeted In Vivo CAR-T Therapy for B Cell-mediated Autoimmune Diseases
Fonte
Aera Therapeutics
Emittente
Business Wire
1.00
0
02/09/2025
Salute
Biotecnologia
Medicina - Varie
Sanità
Farmaceutica
Mercato del lavoro
Aera Therapeutics Appoints Bill Querbes, Ph.D., as Chief Scientific Officer
Fonte
Aera Therapeutics
Emittente
Business Wire
1.00
0
12/05/2025
Mercato del lavoro
Scienza
Igiene alimentare
Biotecnologia
Medicina - Varie
Sanità
Farmaceutica
Salute
Aera Therapeutics Appoints Paul Conrad, Ph.D., MBA, as Chief Business and Financial Officer
Fonte
Aera Therapeutics
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0